Cargando…

Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies

BACKGROUND: Early integration of palliative care (PC) for patients with advanced cancer has been recommended to improve quality of care. This study aims to describe prevalence, temporal trend and predictors of PC use in metastatic breast cancer (mBCa) patients receiving critical care therapies (CCT;...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Lin, Shuchen, Zhu, Yihui, Xu, Rui, Lan, Xiaohong, Xiang, Fang, Li, Xiang, Zhang, Ye, Chen, Shudong, Yu, Hao, Wu, Dongni, Zang, Juxiang, Tang, Jiali, Jin, Jiewen, Han, Hedong, Tao, Zhonghua, Zhou, Yonggang, Hu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679246/
https://www.ncbi.nlm.nih.gov/pubmed/33212422
http://dx.doi.org/10.1016/j.breast.2020.11.001
_version_ 1783612305269850112
author Chen, Ying
Lin, Shuchen
Zhu, Yihui
Xu, Rui
Lan, Xiaohong
Xiang, Fang
Li, Xiang
Zhang, Ye
Chen, Shudong
Yu, Hao
Wu, Dongni
Zang, Juxiang
Tang, Jiali
Jin, Jiewen
Han, Hedong
Tao, Zhonghua
Zhou, Yonggang
Hu, Xichun
author_facet Chen, Ying
Lin, Shuchen
Zhu, Yihui
Xu, Rui
Lan, Xiaohong
Xiang, Fang
Li, Xiang
Zhang, Ye
Chen, Shudong
Yu, Hao
Wu, Dongni
Zang, Juxiang
Tang, Jiali
Jin, Jiewen
Han, Hedong
Tao, Zhonghua
Zhou, Yonggang
Hu, Xichun
author_sort Chen, Ying
collection PubMed
description BACKGROUND: Early integration of palliative care (PC) for patients with advanced cancer has been recommended to improve quality of care. This study aims to describe prevalence, temporal trend and predictors of PC use in metastatic breast cancer (mBCa) patients receiving critical care therapies (CCT; included invasive mechanic ventilation, percutaneous endoscopic gastrostomy tube, total parenteral nutrition, tracheostomy and dialysis). METHODS: The National Inpatient Sample was queried for mBCa patients receiving CCT between 2005 and 2014. Annual percent changes (APC) were calculated for PC prevalence in the overall cohort and subgroups. Multivariable logistic analysis was used to explore predictors of PC use. RESULTS: Of 5833 mBCa patients receiving CCT, 880 (15.09%) received PC. Rate of PC use increased significantly from 2.53% in 2005 to 25.96% in 2014 (APC: 35.75%; p < 0.0001). Higher increase in PC use was observed in South (from 0.65% to 27.11%; APC: 59.42%; p < 0.0001), medium bedsize hospitals (from 3.75% to 26.05%; APC: 38.16%; p = 0.0006) and urban teaching hospitals (from 4.13% to 29.86%; APC: 37.33%; p = 0.0005). Multivariable analysis revealed that year interval, urban teaching hospitals, and invasive mechanical ventilation were associated with increased PC use, while primary diagnosis of gastrointestinal disorders, fractures, metastatic sites from lymph nodes and tracheostomy were associated with lower PC use. CONCLUSIONS: PC use in mBCa patients receiving CCT increases significantly over the period. However, it still remains low. Efforts to illustrate disparities in PC use are needed to improve quality of care for mBCa patients receiving CCT, especially for those hospitalized in rural and nonteaching hospitals.
format Online
Article
Text
id pubmed-7679246
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76792462020-11-27 Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies Chen, Ying Lin, Shuchen Zhu, Yihui Xu, Rui Lan, Xiaohong Xiang, Fang Li, Xiang Zhang, Ye Chen, Shudong Yu, Hao Wu, Dongni Zang, Juxiang Tang, Jiali Jin, Jiewen Han, Hedong Tao, Zhonghua Zhou, Yonggang Hu, Xichun Breast Original Article BACKGROUND: Early integration of palliative care (PC) for patients with advanced cancer has been recommended to improve quality of care. This study aims to describe prevalence, temporal trend and predictors of PC use in metastatic breast cancer (mBCa) patients receiving critical care therapies (CCT; included invasive mechanic ventilation, percutaneous endoscopic gastrostomy tube, total parenteral nutrition, tracheostomy and dialysis). METHODS: The National Inpatient Sample was queried for mBCa patients receiving CCT between 2005 and 2014. Annual percent changes (APC) were calculated for PC prevalence in the overall cohort and subgroups. Multivariable logistic analysis was used to explore predictors of PC use. RESULTS: Of 5833 mBCa patients receiving CCT, 880 (15.09%) received PC. Rate of PC use increased significantly from 2.53% in 2005 to 25.96% in 2014 (APC: 35.75%; p < 0.0001). Higher increase in PC use was observed in South (from 0.65% to 27.11%; APC: 59.42%; p < 0.0001), medium bedsize hospitals (from 3.75% to 26.05%; APC: 38.16%; p = 0.0006) and urban teaching hospitals (from 4.13% to 29.86%; APC: 37.33%; p = 0.0005). Multivariable analysis revealed that year interval, urban teaching hospitals, and invasive mechanical ventilation were associated with increased PC use, while primary diagnosis of gastrointestinal disorders, fractures, metastatic sites from lymph nodes and tracheostomy were associated with lower PC use. CONCLUSIONS: PC use in mBCa patients receiving CCT increases significantly over the period. However, it still remains low. Efforts to illustrate disparities in PC use are needed to improve quality of care for mBCa patients receiving CCT, especially for those hospitalized in rural and nonteaching hospitals. Elsevier 2020-11-07 /pmc/articles/PMC7679246/ /pubmed/33212422 http://dx.doi.org/10.1016/j.breast.2020.11.001 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chen, Ying
Lin, Shuchen
Zhu, Yihui
Xu, Rui
Lan, Xiaohong
Xiang, Fang
Li, Xiang
Zhang, Ye
Chen, Shudong
Yu, Hao
Wu, Dongni
Zang, Juxiang
Tang, Jiali
Jin, Jiewen
Han, Hedong
Tao, Zhonghua
Zhou, Yonggang
Hu, Xichun
Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title_full Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title_fullStr Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title_full_unstemmed Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title_short Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
title_sort prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679246/
https://www.ncbi.nlm.nih.gov/pubmed/33212422
http://dx.doi.org/10.1016/j.breast.2020.11.001
work_keys_str_mv AT chenying prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT linshuchen prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT zhuyihui prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT xurui prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT lanxiaohong prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT xiangfang prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT lixiang prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT zhangye prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT chenshudong prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT yuhao prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT wudongni prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT zangjuxiang prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT tangjiali prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT jinjiewen prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT hanhedong prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT taozhonghua prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT zhouyonggang prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies
AT huxichun prevalencetrendanddisparitiesofpalliativecareutilizationamonghospitalizedmetastaticbreastcancerpatientswhoreceivedcriticalcaretherapies